McGill
Donate  |   Language / La langue: 
You are here:   Cancer and Work Research Helping women prepare for their diagnostic day at the Gattuso Rapid Diagnostic Centre (GRDC)

Helping women prepare for their diagnostic day at the Gattuso Rapid Diagnostic Centre (GRDC)

Dr. Christine Maheu, RN, PhD

Dr. Christine Maheu is an Associate Professor in the Ingram School of Nursing, Faculty of Medicine, McGill University. Dr. Maheu is also an Affiliate Scientist at the University Health Network and the University of Toronto. At McGill University, she teaches research methods, supervises graduate students (masters, doctoral, post-doctoral), mentors practicing nurses and students in research, and conducts research in English and French. She has held research awards with the Canadian Institutes of Health Research, the Canadian Cancer Society, and the Canadian Partnership Against Cancer. These awards funded her research in psychosocial oncology, which focuses on developing and testing psychosocial interventions or measurements tools for various cancer populations. Additionally, in partnership with Ipsos Canada and funded by the Canadian Partnership Against Cancer, she is co-leading a nationwide survey of the needs of cancer patients for transition care from the end of their treatment to three years after their diagnosis. Dr. Maheu received awards for excellence in nursing research (2013, 2015, 2016) from Ovarian Cancer Canada, the Canadian Association of Nurses in Oncology, and the Quebec Association of Nurses in Oncology.

View all Cancer and Work team members


Download information sheet on this study (Microsoft Office .docx format)

For many women, the discovery of a suspicious breast abnormality and obtaining further diagnostic testing can be a source of worry and uncertainty.

What is the study about?

Our study will evaluate the feasibility to provide telephone support prior to and after your visit to the GRDC. The purpose of the study is to test if the provision of a telephone support by a healthcare professional prior to your visit to the GRDC helps to prepare for the day’s event, and to see if receiving telephone support reduces uncertainty and worries.

Who is eligible to participate?

  • Women who have been referred to the GRDC following the discovery of a suspicious breast abnormality

What is expected with your participation in this study?

Your participation involves taking part in a telephone call that would take place prior to your schedule day of testing. The telephone call will take approximately 15 minutes which includes answering questions on your emotional level along with providing you guidance on how to prepare for your diagnostic screening appointment. Following the day of testing, you will be asked to complete a new set of questions. Then, three days following your day of testing, you will receive a second telephone call. Finally, three weeks following you day of testing, you be asked to complete the same set of questions on your emotional level and to review your understanding of the day’s event. These questionnaires can be completed over the telephone with the research coordinator or online, on a secured website.

If you have agreed to participate, please use the following links to complete the set of questions.

Questions:

  1. Prior to your days of testing
  2. Following your day of testing (you attended the GRDC)
  3. Three weeks following your day of testing

More information

If you would like more information, please contact the Study Coordinator:
Lorena Baku 416-581-8631
ELLICSR – Health, Wellness, & Cancer Survivorship Centre
Dr. Christine Maheu, Principal Investigator, Clinical Scientist ELLICSR, University Health Network